期刊文献+

抑制性细胞因子白介素35及其与疾病关系的研究进展 被引量:1

原文传递
导出
摘要 近几年来,关干细胞因子研究的众多进展对于人们深刻理解与认识机体免疫反应的生理功能和病理意义具有十分重要的作用。白介素-35(IL-35)是最近发现的抗炎性细胞因子,能够调节免疫反应,从而阻止及延缓免疫性疾病的发生和发展[1]。研究表明,在人体内它大部分是由调节性T细胞分泌,并且是该细胞发挥免疫调节作用所必须的关键细胞因子[2]。
出处 《中华全科医学》 2015年第2期281-284,共4页 Chinese Journal of General Practice
  • 相关文献

参考文献32

  • 1Collison LW, Workman C J, Kuo Tr,et al. The inhibitory eytokine IL- 35 contributes to regulatory T cell function [ J ]. Nature, 2007,450 ( 169 ) :566-569.
  • 2Chaturvedi V, Collison LW, Guy CS, et al. Cutting edge: Human regu- latory T cells require IL-35 to mediate suppression and infectious toler- ance [ J ]. J Immuno1,2011,186 ( 12 ) :6661-6666.
  • 3Jones LL, Vignali DA. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily [ J ]. Immounol Res, 2011,51 ( 1 ) : 5- 14.
  • 4Collison LW, Delgoffe GM, Guy CS, et al. The composition and signa- ling of the IL-35 receptor are unconventional [ J ]. Nat Immunol,2012, 13 ( 3 ) :290-299.
  • 5Collison LW, Chaturvedi V, Henderson AL, et al. IL-35-mediated in- duction of a potent regulatory T cell population [ J ]. Nat Immunol, 2010,11 ( 12 ) : 1093-1101.
  • 6沈二霞.新型调节性T细胞:iTR35[J].分子诊断与治疗杂志,2012,4(2):142-144. 被引量:4
  • 7Niedbala W, Wei XQ, Cai B, et al. IL-35 is a novel cytokine with ther- apeutic effects against collagen- induced arthritis through the expan- sion of regulatory T cells and suppression of Thl7cells [ J ]. Eur Immu- nol,2007,37( 11 ) :3021-3029.
  • 8Kochetko'ca I, Golden S, I-Ioldemess K, et al. IL-35 stimulation of CD39 + regulatory T cells confers protection against collagen Ⅱ-in- duced arthritis via the production of IL-10 [ J ]. Immunol, 2010,184 (12) :1144-1153.
  • 9Kuo J, Nardelli DT, Warner TF, et al. Interleukin-35 enhances Lyme arthritis in Borrelia-vaecinated and-infected mice [ J ]. Clin Vaccine Immunol,2011,18(7) :1125-1132.
  • 10Whitehead GS,Wilson RH,Nakano K, et al. IL-35 production by in- ducible costimulator(ICOS)-positive regulatory T cells reverses es- tablished IL-17 dependent allergic airways disease[ J]. J Allergy Clin Immunol,2012,129 ( 1 ) :207-215.

二级参考文献87

  • 1FENGNing-han,WUHong-fei,WUJun,ZHANGWei,SUIYuan-gen,HEHou-guang,ZHANGChun-lei,ZHENGJun-song.Immunology Mechanism of CD4^+ CD25^ T Regulatory Cells Acting on Effector T Cells[J].Journal of Nanjing Medical University,2004,18(4):178-182. 被引量:28
  • 2萨京,曾秋棠,王祥,郭和平.Th1/Th2细胞失衡在不稳定型心绞痛发病机制中的作用[J].临床心血管病杂志,2005,21(10):588-590. 被引量:7
  • 3心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:547
  • 4RICHARDSON P, MCKENNA W, BRISTOW M, et al. Report of the 1995 world health organization/international society and federation of cardiology taskforce on the definition and classification of cardiomyopathies [J]. Circulation, 1996, 93:841-- 842.
  • 5NIEDBALA W, WEI X Q, CAI B, et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells [J]. Eur J Immunol, 2007, 37:3021--3029.
  • 6YANG J, YANG M, HTUT TM, et al. Epstein- Barr virus-induced gene 3 negatively regulates IL-17, Iil-22 and RORγt [J]. Eur J Immunol, 2008, 38: 1204--1214.
  • 7COLLISON L W, WORKMAN C J, KUO T T, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function [J]. Nature, 2007, 450:566--569.
  • 8NIEUWENHUIS E E, NEURATH M F, CORAZZA N, et al. Disruption of T helper 2-immune responses in Epstien Barr virus-induced gene 3-deficient mice [J].Proc Natl Acad Sci U S A, 2002, 99..16951-- 16956.
  • 9REDDY J, LLLES Z, ZHANG X, et al. Myelin proteolipid protein-special CD4^+ CD25^+ regulatory ceils mediate genetic resistance to experimental autoimmune encephalomyelitis [J].Proe Natl Aead Sci U S A, 2004, 101:15434--15439.
  • 10COLLISON L W, VIGNALI D A. Interleukin-35: odd one out or part of the family? [J]. Immunol Rev, 2008, 226:248--262.

共引文献48

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部